drugset / Trial / NCT01580488

A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris

NCT01580488

Phase 1 Completed 24 enrolled LEO Pharma
NaSingle-groupSingle-blindOther

Summary

The purpose of the study is to evaluate the anti-psoriatic effect of LEO 35299 in different formulations, compared to Daivonex® ointment and Daivonex® ointment vehicle, using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.

Timeline

Start
2012-04
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical
Subject LEO 35299 Unknown 10 unknown Topical
Subject LEO 35299 Unknown 20 unknown Topical

Indications